Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

The availability of long-acting injectable (LAI) antipsychotics for the treatment of schizophrenia provides clinicians with options that deliver continuous drug exposure and may improve adherence compared with daily oral antipsychotics. However, all LAI antipsychotics have unique formulations and ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Correll, Christoph U., Kim, Edward, Sliwa, Jennifer Kern, Hamm, Wayne, Gopal, Srihari, Mathews, Maju, Venkatasubramanian, Raja, Saklad, Stephen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873121/
https://www.ncbi.nlm.nih.gov/pubmed/33507525
http://dx.doi.org/10.1007/s40263-020-00779-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873121/
https://www.ncbi.nlm.nih.gov/pubmed/33507525
http://dx.doi.org/10.1007/s40263-020-00779-5

Ejemplares similares